Zylox-Tonbridge (02190) Announces Monthly Share Movements and Updated Treasury Shares

Bulletin Express11-04

According to a filing dated 3 November 2025, Zylox-Tonbridge Medical Technology Co., Ltd. (stock code: 02190) reported that as of 31 October 2025, its total authorised share capital remained at RMB 330,182,001, comprising 322,400,744 H Shares and 7,781,257 Domestic Shares.

In terms of issued H Shares, there was a reduction of 947,000 in publicly held shares for the month, bringing the total outstanding H Shares to 315,804,613. Concurrently, treasury H Shares increased by 947,000, reaching 6,596,131 shares in total. Domestic Shares remained unchanged with 7,781,257 shares in issue and no treasury holdings.

Additionally, the company noted two existing share-related plans: a Share Award Scheme adopted on 19 December 2024 and a 2025 Share Incentive Scheme, under which a total of 13,950,000 RSUs have been granted. No new shares were issued pursuant to these plans during the reported period.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment